This compound is a dimeric impurity of ibrutinib, a pharmaceutical reference standard used for quality control in drug manufacturing. It features a complex structure with multiple aromatic rings and heterocycles, reflecting its role as a process-related impurity in the synthesis of ibrutinib.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1288338-97-5
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one
Pharmaceutical impurity reference standard
Risperidone Pyrimidinone-N-oxide
pharmaceutical reference standard impurity
1',4-Dihydroxy Midazolam
pharmaceutical reference standard impurity
Hydrocortisone EP Impurity I
pharmaceutical reference standard impurity
Erythromycin EP Impurity L
pharmaceutical reference standard impurity
Rimegepant
calcitonin gene-related peptide receptor antagonist
Warfarine sodique
active pharmaceutical ingredient
Ergonovine maleate
oxytocic active pharmaceutical ingredient
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-[(3S)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one
YVLRPRSHPNBRSQ-SZAHLOSFSA-N
C1C[C@@H](CN(C1)CCC(=O)N2CCC[C@H](C2)N3C4=NC=NC(=C4C(=N3)C5=CC=C(C=C5)OC6=CC=CC=C6)N)N7C8=NC=NC(=C8C(=N7)C9=CC=C(C=C9)OC1=CC=CC=C1)N
—